alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
*

 This order and judgment is not binding precedent, except under the doctrines of

law of the case, res judicata, and collateral estoppel. The court generally disfavors the

citation of orders and judgments; nevertheless, an order and judgment may be cited under

the terms and conditions of 10th Cir. R. 36.3.

** The Honorable Wesley E. Brown, Senior United States District Judge for the

District of Kansas, sitting by designation.

F I L E D

United States Court of Appeals

Tenth Circuit

DEC 3 1997

PATRICK FISHER

Clerk

UNITED STATES COURT OF APPEALS

TENTH CIRCUIT

 

CHARLES ROSS MANGRUM and

ALAN MONTIERTH,

Plaintiffs-Appellants,

v. No. 96-4164

U.S. WEST COMMUNICATIONS

SERVICES, a Colorado Corporation;

COMMUNICATIONS WORKERS OF

AMERICA, a labor organization;

COMMUNICATIONS WORKERS OF

AMERICA DISTRICT 7, an

administrative unit of a labor

organization; and COMMUNICATIONS

WORKERS OF AMERICA LOCAL NO.

7704, a unit of a labor organization,

Defendants-Appellees.

(D.C. No. 95-CV-587)

(UTAH)

(961 F. Supp. 1510)

 

ORDER AND JUDGMENT*

 

Before BALDOCK and BRORBY, Circuit Judges, and BROWN, Senior District Judge.**

 

Plaintiffs Charles Mangrum and Alan Montierth brought consolidated actions
2

against Defendants U.S. West Communications and Communications Workers of

America, alleging violations of § 301 of the Labor Management Relations Act. Plaintiffs,

both union members and employees of U.S. West, claimed that U.S. West breached the

collective bargaining agreement and the Union breached its duty of fair representation in

a dispute over Plaintiffs “primary reporting place.” Plaintiffs also claimed intentional

infliction of emotional distress. In a thorough opinion, the district court granted both

Defendants summary judgment on all claims. Mangrum v. U.S. West Communications,

Inc., 961 F. Supp. 1510 (D. Utah, 1996). Plaintiffs appeal. We review the district court’s

grant of summary judgment de novo and apply the same standard as the district court

under Fed. R. Civ. P. 56(c). Taken v. Oklahoma Corp. Comm’n, 125 F.3d 1366, 1368

(10th Cir. 1997).

We have reviewed the parties’ briefs, pleadings, affidavits, and the entire record

before us. We believe the district court properly granted summary judgment to

Defendants, and affirm substantially for the reasons set forth in its Memorandum

Decision and Order Granting Defendants’ Motions for Summary Judgment.

AFFIRMED.

Entered for the Court,

Bobby R. Baldock

Circuit Judge
EXHIBIT 32.1
                                                                    ------------


                    Certification pursuant to 18 U.S.C. 1350,
      as adopted pursuant to Section 906 of the Sarbanes-Oxley act of 2002
      --------------------------------------------------------------------



In connection with the accompanying Form 10-K of ZAP for the year ended December
31, 2008, Steven M. Schneider, Director and Chief Executive Officer of ZAP,
hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:

     (1)  such Form 10K of ZAP for the year ended December 31, 2008, fully
          complies with the requirements of Section 13 (a) or 15 (d) of the
          Securities Exchange of 1934; and

     (2)  the information contained in such Form 10-K of ZAP for the year ended
          December 31, 2008, fairly presents, in all material respects, the
          financial condition and results of operations of ZAP.







Date: March 27, 2009                            By: /s/ Steve Schneider
                                                    -------------------------
                                                    Steve Schneider
                                                    Director and
                                                    Chief Executive Officer
EXHIBIT 31.02



Certification of Robert M. Kline, Chief Financial Officer, pursuant to

Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended



I, Robert M. Kline, certify that:



1.

I have reviewed this quarterly report on Form 10-Q/A of Gold Star Tutoring Services, Inc. for the quarterly period ended June 30, 2009;



2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;



3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;



4.

The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:



(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;



(b)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and



(c)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and



5.

The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):



(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and



(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



August 17, 2009

/s/Robert M. Kline__________________

Robert M. Kline, Treasurer

Chief Financial Officer

Principal Accounting and Financial Officer
### THE THIRTEENTH COURT OF APPEALS

13

- 19

- 00139

- CV
In the Interest of W. C. N., a Child
On Appeal from the 94th District Court of Nueces County , Texas Trial Cause No. 2011

- FAM

- 1689C

JUDGMENT THE THIRTEENTH COURT OF APPEALS, having considered this cause on appeal, concludes the appeal should be dismissed . The Court orders the appeal DISMISSED in accordance with its opinion . Costs of the appeal are adjudged against appellant , S.D.L.R

. We further order this decision certified below for observance. June 6 , 2019
[Federal Register Volume 73, Number 28 (Monday, February 11, 2008)]
[Notices]
[Page 7749]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-581]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting of the President's Cancer Panel.
    The meeting will be closed to the public in accordance with the 
provisions set forth in section 552b(c)(9)(B), Title 5 U.S.C., as 
amended, because the premature disclosure of information and the 
discussions would be likely to significantly frustrate implementation 
of recommendations.

    Name of Committee: President's Cancer Panel.
    Date: March 5, 2008.
    Time: 1 p.m. to 3 p.m.
    Agenda: The panel will discuss the report format and 
recommendations for the 2007-2008 meeting series.
    Place: National Cancer Institute, Office of the Director, 
National Institutes of Health, 6116 Executive Blvd., Suite 212, 
Bethesda, MD 20892. (Teleconference.)
    Contact Person: Abby Sandler, PhD, Executive Secretary, National 
Cancer Institute, National Institutes of Health, 6116 Executive 
Blvd., Suite 212, Bethesda, MD 20892, 301-451-9399.
    Any interested person may file written comments with the 
committee by forwarding the comments to the Contact Person listed on 
this notice. The comments should include the name, address, 
telephone number and, when applicable, the business or professional 
affiliation of the interested person. Information is also available 
on the Institute's/Center's home page: deainfo.nci.nih.gov/advisory/pcp/pcp.htm, where an agenda and any additional information for the 
meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: February 1, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-581 Filed 2-8-08; 8:45 am]
BILLING CODE 4140-01-M
EXHIBIT 23 - CONSENT


CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration
Statement No. 333-31536 of Monarch Services, Inc. on Form S-8 of our
report dated July 8, 2004, appearing in the Annual Report on Form
10-KSB of Monarch Services, Inc. for the year ended April 30, 2004.


                                         /s/  Stegman & Company


July 27, 2004
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

                    Notice if hereby given of a change in the meeting of the Integrative and Clinical Endocrinology and Reproduction Study Section, February 4, 2008, 8 a.m. to February 5, 2008, 3 p.m., Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD, 20814 which was published in the                     **Federal Register**                     on January 15, 2008, 73 FR 2513-2516.                

The meeting will be held at the Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. The meeting dates and time remain the same. The meeting is closed to the public.

Dated: January 18, 2008.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 08-300  Filed 1-25-08; 8:45 am]

BILLING CODE 4140-01-M
EXHIBIT 4.12 


 


EXHIBIT D


ALLOCATION OF PURCHASE PRICE


 


	Purchase Price	Tranche	OID/Carried Transaction Expense	Warrant
	
        Initial Cash Purchase Price 

         
	Tranche #1	$57,500	Warrant
	Secured Buyer Note #1 	Tranche #2	$25,000	 
	
        Secured Buyer Note #2 

         
	Tranche #3	$25,000	 
	
        Buyer Note #3 

         
	Tranche #4	$25,000	 
	
        Buyer Note #4

         
	Tranche #5	$25,000
Exhibit 32.1  CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002   The undersigned, Daniel McCormick, the Chief Executive Officer and Lorne R. Gale, Chief Financial Officer of Diamond Information Institute Inc., hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to their knowledge, the Quarterly Report on Form 10-Q of Diamond Information Institute Inc. for quarter ended September 30, 2010, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Diamond Information Institute Inc.   Date: September 21, 2011  /s/ Christopher GloverChristopher Glover
Chief Executive Officer, Secretary  /s/ "Lorne R. Gale"Lorne R. Gale
Chief Financial Officer, Principal Accounting Officer     A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signatures that appear in typed form within the electronic version of this written statement required by Section 906, has been provided to Diamond Information Institute Inc. and will be retained by Diamond Information Institute Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
Advisory Board on Radiation and Worker Health

TBD 6000 Work Group Teleconference

December 14 2016

Conference Phone: 1-866-659-0537; Participant Code: 9933701#

AGENDA

3:00 p.m. Eastern Time

Welcome and roll call

1. SC&A Review of Appendix BB, Rev 02

2. NIOSH responses and SC&A reply

3. Public comments

4. Path forward/Plans for March Board meeting 

Adjourn
AGENDA

Advisory Board on Radiation and Worker Health 

Teleconference of the

Hanford WG 

April 14, 2020

10:00 a.m. (Eastern Daylight Time)

Conference Call Number: 1-866-659-0537

Participant Pass Code: 9933701

Welcome and roll-call/introductions .............................................. Ted Katz, DFO

 

Review of SEC Exposure Issues ..................................................DCAS & SC&A 

Issue 3: Th-232 internal exposure from Jan 1, 1960 onward 

Issue 4: HEU - Uranium Intake Estimation 

Issue 7: U-233 Intakes 

Issue 9: Np-237 Intakes 

Issue 10: Tritium Intake Estimation from 1949 Onwards 

Issue 20: Skin Contamination 

Issue 22: Radiological Incidents 

Issue 27: Building 324 Leaks 

Report

Assessment of Certain Special Exposure Cohort-Related Issues for the Hanford Site., January 7, 2020, 

Rev 0, NIOSH

Review of data adequacy and completeness.......................................DCAS & SC&A

 

Internal Dosimetry Program practices, 1983-1990 

REX internal monitoring database for prime contractors 

Petitioner Comments (optional to Petitioner)................................................Petitioner

Path forward (Action Items/Next WG Meeting/August Board Meeting) ............ WG & Staff 

Adjourn
| 1.   | The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and |
|----------------|--------------------------------------------------------------------------------------------------------------|

| 2.   | The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented. |
|----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| By:    | /s/Owen Gibson                                                        |
|--------|-----------------------------------------------------------------------|
|   |                                                                  |
| Name:  | Owen Gibson                                                           |
|   |                                                                  |
| Title: | Principal Executive Officer, Principal Financial Officer and Director |
|   |                                                                  |
| Date:  | August 17, 2009                                                       |
NIOSH Respiratory Protective Device Information

 NIOSH CA 2021-1038

 August 2021

 

Revocation of Shanghai Dasheng Health Products Manufacture Co., Ltd. 

Approvals
Document Number

NIOSH CA 2021 - 1038

Page 2 of 2

The National Institute for Occupational Safety and Health (NIOSH) has revoked ALL approvals issued to 

Shanghai Dasheng Health Products Manufacture Co., Ltd. The revoked approval numbers are 

provided below. The revocation includes all private label versions. 

As of August 13 , 2021, any Shanghai Dasheng Health Products Manufacture Co., Ltd. respirator 

marked with a NIOSH approval label indicating any of the approval numbers below is no longer 

NIOSH-approved:

TC-84A-4329, TC-84A-4330, TC-84A-4331, TC-84A-4332, TC-84A-4334, TC-84A-4335, TC-84A-4336, TC84A-4337, TC-84A-4398, TC-84A-4399, TC-84A-4400, TC-84A-4401, TC-84A-4463, TC-84A-4464, TC-84A4465, TC-84A-4466, TC-84A-4467, TC-84A-4468, TC-84A-4469, TC-84A-4470, TC-84A-4471, TC-84A4472, TC-84A-4473, TC-84A-4483, TC-84A-4484, TC-84A-4485, TC-84A-4486, TC-84A-4487, TC-84A8150, TC-84A-8425, TC-84A-8543, TC-84A-8544, TC-84A-8545, TC-84A-8546, TC-84A-8547, TC-84A8634, TC-84A-8635, and TC-84A-8636

Revocation also means that respirators bearing any of the NIOSH approval numbers listed above may 

no longer be manufactured, assembled, sold, or distributed. As of August 13, 2021, respirators bearing 

the NIOSH aproval numbers listed above are no longer considered approved and may not be used in 

fullfillment of any standard or statute requiring the use of a NIOSH approved respirator. 

Shanghai Dasheng Health Products Manufacture Co., Ltd. failed to control the design, labeling, and 

quality management as required by 42 C.F.R. Part 84. Thus, NIOSH has revoked these approvals in 

accordance with the authority granted in 42 C.F.R. § 84.34 which states, “The Institute reserves the 

right to revoke, for cause, any certificate of approval issued pursuant to the provisions of this part. Such 

causes include, but are not limited to, misuse of approval labels and markings, misleading advertising, 

and failure to maintain or cause to be maintained the quality control requirements of the certificate of 

approval.”

Revocation of Shanghai Dasheng Health Products Manufacture Co., Ltd. Approvals
a50950942ex10_6.htm


Exhibit 10.6


 


Second Amendment to Custody Agreement







This Second Amendment to that certain Custody Agreement by and between Keating Capital, Inc. n/k/a BDCA Venture, Inc. (“BDCA Venture”) and Steele Street Bank & Trust (the “Custodian”) dated November 18, 2008, as amended on December 21, 2012 (the “Custody Agreement”) is hereby entered into by BDCA Venture and the Custodian as of September 24, 2014.


 


WHEREAS, BDCA Venture and the Custodian desire to modify certain terms of the Custody Agreement so that the custody arrangement includes the custody of securities accounts that hold securities that are held as collateral for margin loans; and


 


WHEREAS, the Board of Directors of BDCA Venture (the “Board”) has approved this Second Amendment to the Custody Agreement (“Second Amendment”); and


 


WHEREAS, all capitalized terms contained in this Second Amendment not otherwise defined herein shall have the meaning ascribed to them in the Custody Agreement; and


 


WHEREAS, BDCA Venture and the Custodian desire to enter into this Second Amendment to modify and amend the terms of the Custody Agreement as set forth herein effective as September 24, 2014; and


 


NOW, THEREFORE, the parties hereto agree as follows:


 


1.  Section 1(a) of Article II (Appointment of Custodian; Accounts; Representations, Warranties, and Covenants) is hereby amended to add the following sentence at the end thereof:


 


“Securities accounts shall include accounts that hold Securities that are held as collateral for margin loans.”


 


2.  All references to “Keating Capital, Inc.” shall be changed to “BDCA Venture, Inc.” All references to “Keating Capital” shall be changed to “BDCA Venture.”


 


3.  Except as set forth herein, the terms and conditions of the Custody Agreement and Addendum A thereto shall remain in full force and effect.


 


[Remainder of this page intentionally left blank.]


 




  





  











  






 


IN WITNESS WHEREOF, BDCA Venture and Custodian have caused this Second Amendment to be executed by their respective officers, thereunto duly authorized, as of the day and year first above written.


 


BDCA Venture, Inc.


 


 


 


By: /s/ Frederic M. Schweiger


       Frederic M. Schweiger, Chief Operating Officer







 


Steele Street Bank & Trust


 







 


By: /s/ Mary K. Rolsch


 


Name (print): Mary K. Rolsch


 


Title: Senior Vice President


 


2
EXHIBIT
32.1
 
 STATEMENT
REQUIRED BY 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT
 TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 In
connection with the Quarterly Report on Form 10-Q of Man Shing Agricultural
Holdings, Inc, (the "Company") for the three months ended September 30, 2009, as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Eddie Cheung, Chief Executive Officer, of the Company, certify
that:
  
 *   the
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
 
 *   information
contained in the Report fairly presents, in all material respects, our
consolidated financial condition and results of operations.
 
 
 /s/ Eddie
Cheung
 Eddie
Cheung
 Chief
Executive Officer
 
 
 Date:
November 10, 2009
 
 
 This
certification accompanies this Report pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the
Sarbanes-Oxley Act of 2002, be deemed filed by us for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended.